Rhythm Biosciences Ltd (ASX:RHY) Records First Commercial Sales of geneType Products
Rhythm Biosciences (ASX:RHY) records its first commercial sales of geneType products, anticipating growth throughout the year.
Rhythm Biosciences (ASX:RHY) records its first commercial sales of geneType products, anticipating growth throughout the year.
C29 Metals (ASX:C29) secures a new exploration licence, expanding the Ulytau Project footprint by 116 km² in Kazakhstan.
Imugene Limited (ASX:IMU) secures FDA Fast Track designation for its allogeneic CAR T-cell therapy azer-cel, advancing treatment for relapsed or refractory diffuse large B-cell lymphoma.
Tivan Limited (ASX:TVN) reports successful testwork, achieving up to 98.8% CaF₂ grades and improved recoveries for the Speewah Fluorite Project.
AIC Mines (ASX:A1M) reports significant growth in Mineral Resources across Jericho and Sandy Creek, reinforcing its strategic position in the Australian mining sector.
Patriot Battery Metals Inc. (ASX:PMT) updates on the Shaakichiuwaanaan Project feasibility study, targeting completion in September 2025.
Coda Minerals (ASX:COD) completes drilling program at Elizabeth Creek, identifying potential resource expansions and exploring cost-reducing processing methods.
Axel REE Limited (ASX:AXL) announces high-grade REE and gallium intercepts at its Brazilian Caladão Project, expanding mineralised area.
Myer Holdings Ltd (ASX:MYR) reports flat total sales and a strategic reset amidst a challenging macro environment, highlighting strong loyalty program growth and financial performance.
AssetOwl Limited (ASX:AO1) negotiates debt reductions with related parties, involving immediate payments and new share issuances.